Search Results - "Kyo T"

Introduction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia.

Authors: Takeuchi, J. Kyo, T. Naito, K. et al.

Source: Leukemia (08876924). Jul2002, Vol. 16 Issue 7, p1259. 8p.

Heterogenous fusion transcripts involving the NUP98 gene and HOXD13 gene activation in a case of acute myeloid leukemia with the t(2;11)(q31;p15) translocation.

Authors: Arai, Y Kyo, T Miwa, H et al.

Source: Leukemia (08876924). Sep2000, Vol. 14 Issue 9, p1621-1629. 9p.

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease.

Authors: Tsuboi, A Oka, Y Kyo, T et al.

Source: Leukemia (08876924). Jun2012, Vol. 26 Issue 6, p1410-1413. 4p. 1 Chart, 1 Graph.

Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.

Authors: Myoken, Y. Sugata, T. Kyo, T. et al.

Source: Journal of Oral Pathology & Medicine. May1995, Vol. 24 Issue 5, p237-240. 4p.

The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis.

Authors: Kako, S Morita, S Sakamaki, H et al.

Source: Bone Marrow Transplantation. Aug2013, Vol. 48 Issue 8, p1077-1083. 7p. 1 Diagram, 3 Charts, 2 Graphs.

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

Authors: Kako, S. Morita, S. Sakamaki, H. et al.

Source: Leukemia (08876924). Feb2011, Vol. 25 Issue 2, p259-265. 7p. 1 Diagram, 4 Charts, 2 Graphs.

Clinical and prognostic significance of cytokine receptor expression in adult acute lymphoblastic leukemia: interleukin-2 receptor α-chain predicts a poor prognosis.

Authors: Nakase, K. Kita, K. Miwa, H. et al.

Source: Leukemia (08876924). Feb2007, Vol. 21 Issue 2, p326-332. 7p. 6 Charts, 3 Graphs.

Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.

Authors: Niimi, H. Harada, H. Harada, Y. et al.

Source: Leukemia (08876924). Apr2006, Vol. 20 Issue 4, p635-644. 10p. 1 Diagram, 3 Charts, 2 Graphs.

Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML.

Authors: Hi˙ramatsu, A. Mi˙wa, H. Shi˙kami˙, M. et al.

Source: Leukemia & Lymphoma. Jan2006, Vol. 47 Issue 1, p89-95. 7p.

Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.

Authors: Nishii, K Usui, E Katayama, N et al.

Source: Leukemia (08876924). Apr2003, Vol. 17 Issue 4, p731. 7p.

Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.

Authors: Nishii, K. Katayama, N. Miwa, H. et al.

Source: Leukemia (08876924). Jul2002, Vol. 16 Issue 7, p1285. 8p.

Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors.

Authors: Nakanishi, M. Tanaka, K. Takahashi, T. et al.

Source: International Journal of Radiation Biology. Jun2001, Vol. 77 Issue 6, p687-694. 8p.

Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome.

Authors: Matsumoto, N Yoneda-Kato, N Iguchi, T et al.

Source: Leukemia (08876924). Oct2000, Vol. 14 Issue 10, p1757-1765. 9p.

Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies.

Authors: Tanaka, K Arif, M Eguchi, M et al.

Source: Leukemia (08876924). Sep99, Vol. 13 Issue 9, p1367-1373. 7p.

Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality.

Authors: Sankar, M Tanaka, K Kumaravel, T S et al.

Source: Leukemia (08876924). Apr98, Vol. 12 Issue 4, p510-516. 7p.

Application of fluorescence in situ hybridization to detect residual leukemic cells with 9;22 and 15;17 translocations.

Authors: Tanaka, K Arif, M Eguchi, M et al.

Source: Leukemia (08876924). Mar97, Vol. 11 Issue 3, p436-440. 5p.

Clinical efficacy of azole therapy for Trichosporon fungemia in patients with acute leukeima

Authors: Nakase, K. Suzuki, K. Kyo, T. et al.

Source: International Journal of Infectious Diseases. Jun2012 Supplement 1, Vol. 16, pe325-e325. 1p.

Trichosporon Septicemia in Patients with Hematological Disorders

Authors: Suzuki, K. Nakase, K. Kyo, T. et al.

Source: International Journal of Infectious Diseases. Dec2008 Supplement 1, Vol. 12, pe277-e277. 1p.

Recurrent IgA1-λ-Type PGNMID Achieving Remission with Conventional Immunosuppressive Therapy.

Authors: Chida K Oura A Takahashi T et al.

Source: Internal medicine (Tokyo, Japan) [Intern Med] 2026 Jun 15; Vol. 65 (12), pp. 1650-1656. Date of Electronic Publication: 2025 Nov 06.

Publication Type: Journal Article; Case Reports

Journal Info: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

Filamin-ETV4/5 acts as mechanosensor-mechanotransducer axis that drives cell competition-mediated elimination of transformed cells.

Authors: Wen J Sai K Masutani S et al.

Source: Nature communications [Nat Commun] 2026 May 21. Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE